Partial upper sternotomy vs full median sternotomy in obese patients undergoing aortic valve replacement: A meta-analysis.

IF 2.8 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Aarushi Gupta, Tinatin Chikhradze, Afrah Arshad, Rahmah Ashar Sakrani, Zainab Khan, Melake Getahun, Samreen Rizwan Ahmed Shaikh, Wajiha Syed, Tanish Baweja, Abhijith Remesan, Cheryl Lewis, Joy Doshi, Muneeb Khawar, Asraf Hussain, Muhammad Muneeb Khawar
{"title":"Partial upper sternotomy <i>vs</i> full median sternotomy in obese patients undergoing aortic valve replacement: A meta-analysis.","authors":"Aarushi Gupta, Tinatin Chikhradze, Afrah Arshad, Rahmah Ashar Sakrani, Zainab Khan, Melake Getahun, Samreen Rizwan Ahmed Shaikh, Wajiha Syed, Tanish Baweja, Abhijith Remesan, Cheryl Lewis, Joy Doshi, Muneeb Khawar, Asraf Hussain, Muhammad Muneeb Khawar","doi":"10.4330/wjc.v17.i9.110838","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Obese patients (body mass index ≥ 30 kg/m²) undergoing isolated aortic valve replacement (AVR) face increased surgical risks due to comorbidities. Partial upper sternotomy (PUS), a minimally invasive approach, may reduce complications compared to full median sternotomy (FMS). We hypothesize that PUS improves outcomes over FMS in obese patients undergoing AVR.</p><p><strong>Aim: </strong>To compare the efficacy and safety of PUS <i>vs</i> FMS in obese patients undergoing isolated AVR.</p><p><strong>Methods: </strong>This systematic review and meta-analysis followed PRISMA guidelines, searching PubMed, EMBASE, and Cochrane databases for observational studies comparing PUS <i>vs</i> FMS in obese patients undergoing AVR. Outcomes were analyzed using odds ratios (OR), mean differences (MD), 95% confidence intervals (CI), <i>I</i>² statistic, and Newcastle-Ottawa Scale was used for quality assessment.</p><p><strong>Results: </strong>Four observational studies involving 677 patients were analyzed. PUS reduced intensive care unit stay (MD -2.67 days, 95%CI: -4.43 to -0.90, <i>P</i> = 0.003, <i>I</i>² = 78%) but increased cardiopulmonary bypass time (MD 5.62 minutes, 95%CI: -0.36 to 11.59, <i>I</i>² = 55%). No differences were observed in renal failure (OR 1.13, 95%CI: 0.63-2.94, <i>I</i>² = 0%), atrial fibrillation (OR 0.81, 95%CI: 0.43-1.54, <i>I</i>² = 30%), reexploration (OR 1.09, 95%CI: 0.48-2.47, <i>I</i>² = 0%), postoperative bleeding (OR 1.48, 95%CI: 0.53-4.15, <i>I</i>² = 60%), wound infection (OR 1.23, 95%CI: 0.70-2.14, <i>I</i>² = 0%), hospital stay (MD 0.51 days, 95%CI: -4.13 to 5.15, <i>I</i>² = 90%), or cross-clamp time (MD 4.03 minutes, 95%CI: -0.75 to 8.80, <i>I</i>² = 50%).</p><p><strong>Conclusion: </strong>PUS is safe and effective for obese patients undergoing AVR, reducing intensive care unit stay and enhancing recovery, provided surgical expertise is available.</p>","PeriodicalId":23800,"journal":{"name":"World Journal of Cardiology","volume":"17 9","pages":"110838"},"PeriodicalIF":2.8000,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12476599/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4330/wjc.v17.i9.110838","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Obese patients (body mass index ≥ 30 kg/m²) undergoing isolated aortic valve replacement (AVR) face increased surgical risks due to comorbidities. Partial upper sternotomy (PUS), a minimally invasive approach, may reduce complications compared to full median sternotomy (FMS). We hypothesize that PUS improves outcomes over FMS in obese patients undergoing AVR.

Aim: To compare the efficacy and safety of PUS vs FMS in obese patients undergoing isolated AVR.

Methods: This systematic review and meta-analysis followed PRISMA guidelines, searching PubMed, EMBASE, and Cochrane databases for observational studies comparing PUS vs FMS in obese patients undergoing AVR. Outcomes were analyzed using odds ratios (OR), mean differences (MD), 95% confidence intervals (CI), I² statistic, and Newcastle-Ottawa Scale was used for quality assessment.

Results: Four observational studies involving 677 patients were analyzed. PUS reduced intensive care unit stay (MD -2.67 days, 95%CI: -4.43 to -0.90, P = 0.003, I² = 78%) but increased cardiopulmonary bypass time (MD 5.62 minutes, 95%CI: -0.36 to 11.59, I² = 55%). No differences were observed in renal failure (OR 1.13, 95%CI: 0.63-2.94, I² = 0%), atrial fibrillation (OR 0.81, 95%CI: 0.43-1.54, I² = 30%), reexploration (OR 1.09, 95%CI: 0.48-2.47, I² = 0%), postoperative bleeding (OR 1.48, 95%CI: 0.53-4.15, I² = 60%), wound infection (OR 1.23, 95%CI: 0.70-2.14, I² = 0%), hospital stay (MD 0.51 days, 95%CI: -4.13 to 5.15, I² = 90%), or cross-clamp time (MD 4.03 minutes, 95%CI: -0.75 to 8.80, I² = 50%).

Conclusion: PUS is safe and effective for obese patients undergoing AVR, reducing intensive care unit stay and enhancing recovery, provided surgical expertise is available.

Abstract Image

Abstract Image

Abstract Image

接受主动脉瓣置换术的肥胖患者部分胸骨上切开术vs完全胸骨正中切开术:一项meta分析。
背景:肥胖患者(体重指数≥30 kg/m²)接受孤立性主动脉瓣置换术(AVR),由于合并症,手术风险增加。部分胸骨上切开术(PUS)是一种微创入路,与完全胸骨正中切开术(FMS)相比,可以减少并发症。我们假设脓液可以改善肥胖AVR患者FMS的预后。目的:比较PUS与FMS在肥胖孤立性AVR患者中的疗效和安全性。方法:本系统综述和荟萃分析遵循PRISMA指南,检索PubMed、EMBASE和Cochrane数据库,比较PUS与FMS在AVR肥胖患者中的观察性研究。结果分析采用优势比(OR)、平均差异(MD)、95%置信区间(CI)、I²统计量,并采用纽卡斯尔-渥太华量表进行质量评价。结果:分析了4项观察性研究,涉及677例患者。PUS减少了重症监护病房的住院时间(MD -2.67天,95%CI: -4.43 ~ -0.90, P = 0.003, I²= 78%),但增加了体外循环时间(MD 5.62分钟,95%CI: -0.36 ~ 11.59, I²= 55%)。在肾功能衰竭(OR 1.13, 95%CI: 0.63-2.94, I²= 0%)、心房颤动(OR 0.81, 95%CI: 0.43-1.54, I²= 30%)、再探查(OR 1.09, 95%CI: 0.48-2.47, I²= 0%)、术后出血(OR 1.48, 95%CI: 0.53-4.15, I²= 60%)、伤口感染(OR 1.23, 95%CI: 0.70-2.14, I²= 0%)、住院时间(MD 0.51天,95%CI: -4.13 - 5.15, I²= 90%)、交叉钳夹时间(MD 4.03分钟,95%CI: -0.75 - 8.80, I²= 50%)方面均无差异。结论:在具备外科专业知识的情况下,脓液治疗肥胖AVR患者安全有效,可缩短重症监护时间,促进康复。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
World Journal of Cardiology
World Journal of Cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
3.30
自引率
5.30%
发文量
54
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信